Andrew Minchinton obtained a PhD at the Middlesex Hospital Medical School/University College London and Gray Laboratory in the UK. After a post-doctoral fellowship in Vancouver and a 3-year stint as a staff scientist at Stanford University with J. Martin Brown, he was recruited to the BC Cancer Research Centre scientific faculty and is now a Distinguished Scientist in the Department of Integrative Oncology and Head of the Radiation Biology Unit. He also holds a faculty appointment in Pathology & Laboratory Medicine at the University of British Columbia and teaches Radiation Biophysics in the Department of Physics and Astronomy.
Major interests include how the tumour microenvironment influences radiotherapy outcome with particular interest in oxygen and the electron transport chain, extravascular drug distribution and DNA damage repair and drug discovery. Most recently focus has been on translational developments to discover a cancer targeted inhibitor of a pivotal DNA repair proteins as well as fundamental experiments on FLASH radiotherapy.
Dr. Minchinton has published over 100 peer-reviewed articles, 5 patents and currently holds two CIHR operating grants. Recent accolades include the Robert F. Kallman award for academic leadership, scientific excellence, service to the profession and commitment to colleagues, students and Stanford University.